BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23979311)

  • 1. Choroidal thickness in convalescent vogt-koyanagi-harada disease.
    Takahashi H; Takase H; Ishizuka A; Miyanaga M; Kawaguchi T; Ohno-Matsui K; Mochizuki M
    Retina; 2014 Apr; 34(4):775-80. PubMed ID: 23979311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC; Cho IH; Lee EK; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.
    Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A
    Retina; 2012; 32(10):2061-9. PubMed ID: 23095726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
    Inomata H; Rao NA
    Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of choroidal structure after corticosteroid treatment in eyes with Vogt-Koyanagi-Harada disease.
    Egawa M; Mitamura Y; Akaiwa K; Semba K; Kinoshita T; Uchino E; Sonoda S; Sakamoto T
    Br J Ophthalmol; 2016 Dec; 100(12):1646-1650. PubMed ID: 26906951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
    Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
    Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.
    Lee EK; Lee SY; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):359-68. PubMed ID: 25017008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroidal thickness in eyes with posterior recurrence of Vogt-Koyanagi-Harada disease after high-dose steroid therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Acta Ophthalmol; 2014 Sep; 92(6):e490-1. PubMed ID: 24588838
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease.
    Guo YL; Du Y; He JF
    Am J Ophthalmol; 2009 May; 147(5):946; author reply 946-7. PubMed ID: 19376333
    [No Abstract]   [Full Text] [Related]  

  • 11. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUBFOVEAL CHOROIDAL THICKNESS IN PAPILLITIS TYPE OF VOGT-KOYANAGI-HARADA DISEASE AND IDIOPATHIC OPTIC NEURITIS.
    Maruko I; Iida T; Sugano Y; Go S; Sekiryu T
    Retina; 2016 May; 36(5):992-9. PubMed ID: 26509220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease.
    da Silva FT; Sakata VM; Nakashima A; Hirata CE; Olivalves E; Takahashi WY; Costa RA; Yamamoto JH
    Br J Ophthalmol; 2013 Jan; 97(1):70-4. PubMed ID: 23099292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease.
    Jap A; Luu CD; Yeo I; Chee SP
    Eye (Lond); 2008 Feb; 22(2):240-5. PubMed ID: 16980924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease.
    Tagawa Y; Namba K; Mizuuchi K; Takemoto Y; Iwata D; Uno T; Fukuhara T; Hirooka K; Kitaichi N; Ohno S; Ishida S
    Br J Ophthalmol; 2016 Apr; 100(4):473-7. PubMed ID: 26261230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
    Nakai K; Gomi F; Ikuno Y; Yasuno Y; Nouchi T; Ohguro N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1089-95. PubMed ID: 22240936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
    Hirooka K; Saito W; Namba K; Mizuuchi K; Iwata D; Hashimoto Y; Ishida S
    PLoS One; 2017; 12(2):e0172612. PubMed ID: 28241069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired myopia in Vogt-Koyanagi-Harada disease.
    Takahashi H; Takase H; Terada Y; Mochizuki M; Ohno-Matsui K
    Int Ophthalmol; 2019 Mar; 39(3):521-531. PubMed ID: 29397539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
    Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N
    Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.